Literature DB >> 21646872

The effects of nonsteroidal anti-inflammatory drugs on blood pressure in hypertensive patients.

Stanley Snowden1, Robert Nelson.   

Abstract

Nonsteroidal anti-inflammatory drugs (NSAIDs) are ubiquitous medications used by a wide range of people from otherwise healthy normotensive patients to hypertensive patients with many significant comorbidities. Through a variety of mechanisms related to prostaglandin inhibition, including sodium retention and vasoconstriction, these agents may increase blood pressure. This leads to potentially detrimental effects. A review of the current literature regarding this topic yielded 2 meta-analyses and 10 randomized controlled trials. There is evidence of small blood pressure increases in normotensive patients taking NSAIDs approximating +1.1 mm Hg. Patients with treated hypertension show variable increases with NSAID treatment, ranging up to +14.3 mm Hg for systolic pressure and +2.3 mm Hg for diastolic blood pressure. Most antihypertensive medications seem to have decreased effects with concomitant NSAID administration, with the exception of calcium channel blockers. Given the current literature, it appears that NSAIDs increase blood pressure in patients with controlled-hypertension, but the quantity of this increase is variable. If possible, patients who have hypertension should avoid taking NSAIDs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21646872     DOI: 10.1097/CRD.0b013e31821ddcf4

Source DB:  PubMed          Journal:  Cardiol Rev        ISSN: 1061-5377            Impact factor:   2.644


  17 in total

Review 1.  Hypertension as a cardiovascular risk factor in autoimmune rheumatic diseases.

Authors:  Elena Bartoloni; Alessia Alunno; Roberto Gerli
Journal:  Nat Rev Cardiol       Date:  2017-08-24       Impact factor: 32.419

2.  KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors.

Authors:  Krista L Lentine; Bertram L Kasiske; Andrew S Levey; Patricia L Adams; Josefina Alberú; Mohamed A Bakr; Lorenzo Gallon; Catherine A Garvey; Sandeep Guleria; Philip Kam-Tao Li; Dorry L Segev; Sandra J Taler; Kazunari Tanabe; Linda Wright; Martin G Zeier; Michael Cheung; Amit X Garg
Journal:  Transplantation       Date:  2017-08       Impact factor: 4.939

3.  Non-steroidal anti-inflammatory drugs (NSAIDs) and hypertension treatment intensification: a population-based cohort study.

Authors:  Jean-Pascal Fournier; Agnès Sommet; Robert Bourrel; Stéphane Oustric; Atul Pathak; Maryse Lapeyre-Mestre; Jean-Louis Montastruc
Journal:  Eur J Clin Pharmacol       Date:  2012-04-15       Impact factor: 2.953

Review 4.  The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings.

Authors:  Garry G Graham; Michael J Davies; Richard O Day; Anthoulla Mohamudally; Kieran F Scott
Journal:  Inflammopharmacology       Date:  2013-05-30       Impact factor: 4.473

5.  International Union of Basic and Clinical Pharmacology. CIX. Differences and Similarities between Human and Rodent Prostaglandin E2 Receptors (EP1-4) and Prostacyclin Receptor (IP): Specific Roles in Pathophysiologic Conditions.

Authors:  Xavier Norel; Yukihiko Sugimoto; Gulsev Ozen; Heba Abdelazeem; Yasmine Amgoud; Amel Bouhadoun; Wesam Bassiouni; Marie Goepp; Salma Mani; Hasanga D Manikpurage; Amira Senbel; Dan Longrois; Akos Heinemann; Chengcan Yao; Lucie H Clapp
Journal:  Pharmacol Rev       Date:  2020-10       Impact factor: 25.468

Review 6.  Non-steroidal anti-inflammatory drug use in chronic pain conditions with special emphasis on the elderly and patients with relevant comorbidities: management and mitigation of risks and adverse effects.

Authors:  Martin Wehling
Journal:  Eur J Clin Pharmacol       Date:  2014-08-28       Impact factor: 2.953

7.  Tolerability of diclofenac sodium 1% gel with concomitant medications known to interact with diclofenac.

Authors:  John H Peniston; Morris S Gold; Matthew S Wieman; Lawrence K Alwine
Journal:  Ther Clin Risk Manag       Date:  2013-04-16       Impact factor: 2.423

8.  Effect of total knee arthroplasty on type II diabetes mellitus and hypertension: A prospective study.

Authors:  Shrinand V Vaidya; Arvind Arora; Ambarish A Mathesul
Journal:  Indian J Orthop       Date:  2013-01       Impact factor: 1.251

9.  Evaluation of blood pressure and heart rate in patients with hypertension who received tapentadol extended release for chronic pain: a post hoc, pooled data analysis.

Authors:  David M Biondi; Jim Xiang; Mila Etropolski; Bruce Moskovitz
Journal:  Clin Drug Investig       Date:  2014-08       Impact factor: 2.859

10.  Evidence that links loss of cyclooxygenase-2 with increased asymmetric dimethylarginine: novel explanation of cardiovascular side effects associated with anti-inflammatory drugs.

Authors:  Blerina Ahmetaj-Shala; Nicholas S Kirkby; Rebecca Knowles; Malak Al'Yamani; Sarah Mazi; Zhen Wang; Arthur T Tucker; Louise Mackenzie; Paul C J Armstrong; Rolf M Nüsing; James A P Tomlinson; Timothy D Warner; James Leiper; Jane A Mitchell
Journal:  Circulation       Date:  2014-12-09       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.